Biological basis of cravings The hormone that these drugs mimic GLP-1 is not only produced in the gut
Although the reactions catalysed by Gdh2 and Gdh3 are reversible, the Gdh2-catalysed reaction favours the deamination of glutamateits catabolism to -ketoglutarate and ammonium 12
Obesity and cardiovascular risk At obesity doses (e.g., semaglutide 2.4 mg / Wegovy), average weight loss in trials is around 15% of body weight , with improvements in BP, lipids, sleep apnea severity, mobility, and quality of life
I love this product easy to use and gets into the skin to do it's work for sure
Published October 22, 2025
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have proven effectiveness in stimulating weight loss, as well as enhancing metabolic parameters